PHYSICIAN IMPAIRMENT BY SUBSTANCE ABUSE
O'Connor P, Spickard A. PHYSICIAN IMPAIRMENT BY SUBSTANCE ABUSE. Medical Clinics Of North America 1997, 81: 1037-1052. PMID: 9222267, DOI: 10.1016/s0025-7125(05)70562-9.Peer-Reviewed Original ResearchConceptsSubstance abusePhysician impairmentIllicit drug abusePrevalence of alcoholSubstance abuse problemsImpaired physiciansGeneral populationTreatment approachesPrescription drugsPhysiciansDrug abuseAbuse problemsImpairmentMedicolegal standpointCare organizationsPatientsImproved attentionAbuseHospitalPrevalenceSustained-release methylphenidate for cognitive impairment in HIV-1- infected drug abusers: a pilot study
van Dyck CH, McMahon TJ, Rosen MI, O'Malley SS, O'Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR. Sustained-release methylphenidate for cognitive impairment in HIV-1- infected drug abusers: a pilot study. Journal Of Neuropsychiatry 1997, 9: 29-36. PMID: 9017526, DOI: 10.1176/jnp.9.1.29.Peer-Reviewed Original ResearchMeSH KeywordsAdultAttentionCentral Nervous System StimulantsCognition DisordersDelayed-Action PreparationsDouble-Blind MethodFemaleHIV InfectionsHIV-1HumansLearningMaleMemoryMethylphenidateMiddle AgedNeuropsychological TestsOpioid-Related DisordersPilot ProjectsPsychomotor PerformanceSubstance-Related DisordersConceptsSustained-release methylphenidateCognitive impairmentDouble-blind placebo-controlled crossover trialPlacebo-controlled crossover trialComposite neuropsychological measuresImpaired neuropsychological test performanceClinical improvementPlacebo treatmentCrossover trialMethadone patientsNeuropsychological test performancePlacebo performancePsychostimulant drugsDrug abusersPatientsStudy designPilot studySubstance abusersImpairmentNeuropsychological measuresMethylphenidateMore improvementAbusersTreatmentTest performance